TEVA UK LIMITED v GILEAD SCIENCES, INC
2020 ◽
Vol 137
(3)
◽
pp. 163-186
Abstract H1 Supplementary protection certificates – Anti-retroviral medication – Validity – Combination of active ingredients – Construction of art. 3(a) of the SPC Regulation – Whether product “protected by the basic patent in force” – Whether extent of protection the relevant test – Issue referred to Court of Justice – Interpretation and application of judgment of Court of Justice – Appeal to Court of Appeal
2013 ◽
Vol 107
(3)
◽
pp. 632-638
Keyword(s):
2009 ◽
Vol 37
(2)
◽
pp. 219-238
◽